 Patients receive 18F NaF and 18F FDG intravenously IV over 30 seconds-1 minute and then undergo PETMRI and contrast-enhanced MRI after 45-60 minutes. Patients undergo imaging at baseline, after course 3 12 weeks, and after course 6 24 weeks of treatment with Ra-223. 